Kamada Raises $51.6 Million in Nasdaq IPO

At $9.25, the issue price for the Israeli pharmaceutical developer was 16.6% below the share's closing price in Tel Aviv the previous day.

Yoram Gabison
Send in e-mailSend in e-mail
Yoram Gabison

Comments